{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:13:44Z","timestamp":1791170024275,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T00:00:00Z","timestamp":1409875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0106742","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T18:56:32Z","timestamp":1409943392000},"page":"e106742","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":83,"title":["Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma"],"prefix":"10.1371","volume":"9","author":[{"given":"Robin","family":"Cornelissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysanne A.","family":"Lievense","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Maat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi W.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk C.","family":"Hoogsteden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad J.","family":"Bogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P.","family":"Hegmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"NJ Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","article-title":"Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada","volume":"23","author":"JP Van Meerbeeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref3","volume":"135","unstructured":"Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, <etal>et al<\/etal>.. (2008) Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg <volume>135<\/volume>: : 620\u2013626, 626.e1\u20133. doi:10.1016\/j.jtcvs.2007.10.054"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"HR Alexander Jr","year":"2013","journal-title":"Surgery"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2012.12.005","article-title":"Malignant Pleural Mesothelioma","volume":"34","author":"AR Haas","year":"2013","journal-title":"Clinics in Chest Medicine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jnci\/djp061","article-title":"Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma","volume":"101","author":"GJ Gordon","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00262-011-1073-8","article-title":"Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients","volume":"60","author":"K Suzuki","year":"2011","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00262-010-0881-6","article-title":"CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection","volume":"59","author":"N Yamada","year":"2010","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jtcvs.2007.10.026","article-title":"Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma","volume":"135","author":"M Anraku","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Cornelissen R, Heuvers ME, Maat AP, Hendriks RW, Hoogsteden HC, <etal>et al<\/etal>.. (2012) New Roads Open Up for Implementing Immunotherapy in Mesothelioma. Clinical and Developmental Immunology: 1\u201313. doi:10.1155\/2012\/927240","DOI":"10.1155\/2012\/927240"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1002\/cncr.26143","article-title":"Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma","volume":"117","author":"BM Burt","year":"2011","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Lan C, Huang X, Lin S, Huang H, Cai Q, <etal>et al<\/etal>.. (2012) Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer. Technol Cancer Res Treat.","DOI":"10.7785\/tcrt.2012.500312"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.7314\/APJCP.2013.14.2.1003","article-title":"Correlations of Tumor-associated Macrophage Subtypes with Liver Metastases of Colorectal Cancer","volume":"14","author":"Y-L Cui","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2407-12-306","article-title":"The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients","volume":"12","author":"C Medrek","year":"2012","journal-title":"BMC cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exer.2012.11.012","article-title":"M2\/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles","volume":"107","author":"MC Herwig","year":"2013","journal-title":"Exp Eye Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1827.2010.02514.x","article-title":"Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL)","volume":"60","author":"D Niino","year":"2010","journal-title":"Pathol Int"},{"key":"ref17","unstructured":"Becker M, M\u00fcller CB, De Bastiani MA, Klamt F (2013) The prognostic impact of tumor-associated macrophages and intra-tumoral apoptosis in non-small cell lung cancer. Histol Histopathol."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: balance, tolerance, and diversity","volume":"22","author":"A Mantovani","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Lievense LA, Bezemer K, Aerts JGJV, Hegmans JPJJ (2013) Tumor-associated macrophages in thoracic malignancies. Lung Cancer. doi:10.1016\/j.lungcan.2013.02.017","DOI":"10.1016\/j.lungcan.2013.02.017"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1200\/JCO.2005.07.050","article-title":"Statistical Validation of the EORTC Prognostic Model for Malignant Pleural Mesothelioma Based on Three Consecutive Phase II Trials","volume":"23","author":"DA Fennell","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1183\/09031936.06.00135305","article-title":"Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses","volume":"27","author":"JPJJ Hegmans","year":"2006","journal-title":"Eur Respir J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1479-5876-9-216","article-title":"Identification and manipulation of tumor associated macrophages in human cancers","volume":"9","author":"M Heusinkveld","year":"2011","journal-title":"Journal of Translational Medicine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/jnci\/djs235","article-title":"Macrophages: cancer therapy&apos;s double-edged sword","volume":"104","author":"V Brower","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"201026","DOI":"10.1155\/2010\/201026","article-title":"Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation","volume":"2010","author":"MC Schmid","year":"2010","journal-title":"J Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","article-title":"Differential macrophage programming in the tumor microenvironment","volume":"33","author":"B Ruffell","year":"2012","journal-title":"Trends Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/JTO.0b013e3182037b76","article-title":"The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer","volume":"6","author":"RM Bremnes","year":"2011","journal-title":"J Thorac Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e72249","DOI":"10.1371\/journal.pone.0072249","article-title":"IFN-\u03b3-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1","volume":"8","author":"S De Kleijn","year":"2013","journal-title":"PLoS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.coi.2011.12.009","article-title":"Targeting the PD-1\/B7-H1(PD-L1) pathway to activate anti-tumor immunity","volume":"24","author":"SL Topalian","year":"2012","journal-title":"Current Opinion in Immunology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape","volume":"4","author":"JM Taube","year":"2012","journal-title":"Science Translational Medicine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"A Scherpereel","year":"2009","journal-title":"European Respiratory Journal"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e47045","DOI":"10.1371\/journal.pone.0047045","article-title":"The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer","volume":"7","author":"S Edin","year":"2012","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/jcmm.12109","article-title":"The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients","volume":"17","author":"F Pantano","year":"2013","journal-title":"J Cell Mol Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00262-014-1543-x","article-title":"Salmonella-mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacity","volume":"63","author":"S Kaimala","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1054\/bjoc.2000.1384","article-title":"Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma","volume":"83","author":"Y Soini","year":"2000","journal-title":"Br J Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1172\/JCI3169","article-title":"Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat","volume":"102","author":"S Tanaka","year":"1998","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bjc.6605814","article-title":"Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma","volume":"103","author":"JD Veltman","year":"2010","journal-title":"Br J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1158\/0008-5472.CAN-09-1451","article-title":"Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice","volume":"69","author":"BK Popivanova","year":"2009","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1479-5876-9-177","article-title":"Tumour macrophages as potential targets of bisphosphonates","volume":"9","author":"TL Rogers","year":"2011","journal-title":"J Transl Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/imm.12023","article-title":"Anti-tumour strategies aiming to target tumour-associated macrophages","volume":"138","author":"X Tang","year":"2013","journal-title":"Immunology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"SK Biswas","year":"2010","journal-title":"Nat Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"GL Beatty","year":"2011","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20080108","article-title":"\u201cRe-educating\u201d tumor-associated macrophages by targeting NF-kappaB","volume":"205","author":"T Hagemann","year":"2008","journal-title":"J Exp Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1158\/0008-5472.CAN-04-4262","article-title":"Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection","volume":"65","author":"C Guiducci","year":"2005","journal-title":"Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.20080124","article-title":"An antiinflammatory role for IKKbeta through the inhibition of \u201cclassical\u201d macrophage activation","volume":"205","author":"CHY Fong","year":"2008","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1423-0127-17-32","article-title":"Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination","volume":"17","author":"C-M Chuang","year":"2010","journal-title":"J Biomed Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2567.2010.03357.x","article-title":"Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages","volume":"132","author":"IN Buhtoiarov","year":"2011","journal-title":"Immunology"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, <etal>et al<\/etal>.. (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. doi:10.1038\/nm.3337","DOI":"10.1038\/nm.3337"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1165\/rcmb.2010-0080OC","article-title":"Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells","volume":"44","author":"ZG Fridlender","year":"2011","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0106742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:15:53Z","timestamp":1588990553000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0106742"}},"subtitle":[],"editor":[{"given":"Nupur","family":"Gangopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,5]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0106742","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,5]]}}}